Ahmed Kotb, Hematologist and Bone marrow transplanter at King Faisal Specialist Hospital International Holding Company, shared a post on X:
“Ph-like ALL Signaling Pathways and Targets.
JAK-STAT Signaling:
- Altered by CRLF2, JAK2, EPOR
- Targets: JAK inhibitors, PI3K/mTOR inhibitors
ABL Signaling:
- Fusion proteins (ABL1/2, PDGFRA/B)
- Targets: Kinase inhibitors (dasatinib)
Other Signaling:
- Rare fusion(NTRK3, FLT3.”
More posts featuring Ahmed Kotb.